Sagittarius Life Science Corp. announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was TWD 95.418 million compared to TWD 112.841 million a year ago. Operating loss was TWD 26.250 million compared to TWD 36.360 million a year ago. Net loss was TWD 22.128 million compared to TWD 30.655 million a year ago. Basic loss per share was TWD 0.67 compared to TWD 0.94 a year ago. For the nine months, sales was TWD 313.547 million compared to TWD 364.078 million a year ago. Operating loss was TWD 77.999 million compared to TWD 34.248 million a year ago. Net loss was TWD 54.087 million compared to TWD 61.549 million a year ago. Basic loss per share was TWD 1.65 compared to TWD 1.88 a year ago.